Literature DB >> 22749756

Lung cancer prognosis in Spain: the role of histology, age and sex.

D Salmerón1, M D Chirlaque, M Isabel Izarzugaza, M J Sánchez, R Marcos-Gragera, E Ardanaz, J Galceran, A Mateos, C Navarro.   

Abstract

Survival in the case of lung cancer patients not only remains poor and decreases with advancing age at diagnosis, but recent European studies also report that it differs by sex. Our study sought to describe sex-related differences in lung cancer survival in Spain, and evaluate the role played by histologic type. Our analysis covered seven Spanish regions with population-based cancer registries. Cases diagnosed with lung cancer during the period 1995-1999 were followed up until December 31, 2004. To ascertain possible sex differences we performed multiple regression analysis. Age-standardized 5-year relative survival proved significantly higher in women (11.8%) than in men (9.2%), and among the youngest patients relative survival at 5 years conditional on surviving 1 year, was 1.74 times significantly higher in women than in men. The regression analysis showed that men had a higher relative excess risk of dying (RER) than did women (1.1 [95% CI 1.03-1.18]), with this being particularly marked among the 15-54 age group (1.42 [1.24-1.64]). Analysis by histologic type showed that in small cell carcinoma, men had a higher RER than women (1.29 [1.02-1.61]); in squamous cell carcinoma, men had a significantly lower RER than women during the first and fifth years; and in large cell carcinoma and adenocarcinoma, the RER displayed no significant sex-related differences. Lung cancer survival rates in Spain are poor, with better prognosis in women, especially among patients aged under 55 years at diagnosis, or those with small cell carcinoma.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22749756     DOI: 10.1016/j.rmed.2012.06.006

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  19 in total

1.  Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.

Authors:  M D Chirlaque; D Salmerón; J Galceran; A Ameijide; A Mateos; A Torrella; R Jiménez; N Larrañaga; R Marcos-Gragera; E Ardanaz; M Sant; P Minicozzi; C Navarro; M J Sánchez
Journal:  Clin Transl Oncol       Date:  2017-07-17       Impact factor: 3.405

Review 2.  SEOM clinical guidelines for the treatment of small-cell lung cancer 2013.

Authors:  M Dómine Gómez; T Morán Bueno; A Artal Cortés; J Remon Masip; P Lianes Barragán
Journal:  Clin Transl Oncol       Date:  2013-09-05       Impact factor: 3.405

3.  Association between serum C-reactive protein value and prognosis of patients with non-small cell lung cancer: a meta-analysis.

Authors:  Xiyue Jing; Chongbiao Huang; Hongyu Zhou; Changping Li; Linlin Fan; Jiageng Chen; Guan Zhang; Yuanyuan Liu; Zhuang Cui; Daliang Qi; Jun Ma
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Tumor-stroma ratio is an independent predictor for survival in NSCLC.

Authors:  Tiehong Zhang; Jun Xu; Hongchang Shen; Wei Dong; Yang Ni; Jiajun Du
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.

Authors:  I Linares; E Molina-Portillo; J Expósito; J A Baeyens; C Suárez; M J Sánchez
Journal:  Clin Transl Oncol       Date:  2015-09-02       Impact factor: 3.405

6.  High percentage of α1-globulin in serum protein is associated with unfavorable prognosis in non-small cell lung cancer.

Authors:  Xiao Qu; Zhaofei Pang; Weiwei Yi; Ying Wang; Kai Wang; Qi Liu; Jiajun Du
Journal:  Med Oncol       Date:  2014-09-13       Impact factor: 3.064

7.  Patient, tumor, and healthcare factors associated with regional variability in lung cancer survival: a Spanish high-resolution population-based study.

Authors:  M Rodríguez-Barranco; E Salamanca-Fernández; M L Fajardo; E Bayo; Y-L Chang-Chan; J Expósito; C García; J Tallón; P Minicozzi; M Sant; D Petrova; M A Luque-Fernandez; M-J Sánchez
Journal:  Clin Transl Oncol       Date:  2018-10-19       Impact factor: 3.405

Review 8.  Lung cancer in women: an overview with special focus on Spanish women.

Authors:  J Remon; E Molina-Montes; M Majem; P Lianes; D Isla; P Garrido; E Felip; N Viñolas; J de Castro; A Artal; M-J Sánchez
Journal:  Clin Transl Oncol       Date:  2013-11-26       Impact factor: 3.405

9.  The role of plasma miRNAs in the diagnosis of pulmonary nodules.

Authors:  Ke-Xing Xi; Xue-Wen Zhang; Xiang-Yang Yu; Wei-Dong Wang; Ke-Xiang Xi; Yong-Qiang Chen; Ying-Sheng Wen; Lan-Jun Zhang
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

10.  Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival.

Authors:  Ke-Xing Xi; Ying-Sheng Wen; Chong-Mei Zhu; Xiang-Yang Yu; Rong-Qing Qin; Xue-Wen Zhang; Yong-Bin Lin; Tie-Hua Rong; Wei-Dong Wang; Yong-Qiang Chen; Lan-Jun Zhang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.